Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
New Insights into How Mutant p53 Promotes Tumor Growth

New Insights into How Mutant p53 Promotes Tumor Growth

Researchers on the Brink of a Scientific Breakthrough in Cancer Treatment

Researchers on the Brink of a Scientific Breakthrough in Cancer Treatment

Study Identifies Key Macrophage Subpopulations in MASH Progression and Regression

Study Identifies Key Macrophage Subpopulations in MASH Progression and Regression

Uncovering the Molecular Mechanisms Underlying Liver Regeneration

Uncovering the Molecular Mechanisms Underlying Liver Regeneration

Study Identifies Microproteins as Key Source of Tumor-Specific Antigens in Liver Cancer

Study Identifies Microproteins as Key Source of Tumor-Specific Antigens in Liver Cancer

Liver Blood Vessels Trigger 'Sleep Timer' to Inactivate Immune Cells in Chronic Hepatitis B

Liver Blood Vessels Trigger 'Sleep Timer' to Inactivate Immune Cells in Chronic Hepatitis B

Study Uncovers Cells' Surprising Strategy to Control Signaling Pathways

Study Uncovers Cells' Surprising Strategy to Control Signaling Pathways

Rare YKT6 Gene Variants Linked to New Neurological Disorder

Rare YKT6 Gene Variants Linked to New Neurological Disorder

Machine Learning Reveals Cancer-Causing DNA Repeats

Machine Learning Reveals Cancer-Causing DNA Repeats

Unveiling the Role of Exosomes in Regulating Hepatic Lipid Metabolism

Unveiling the Role of Exosomes in Regulating Hepatic Lipid Metabolism

GEMINI Test Uses Genome-Wide Sequencing to Detect Cancer

GEMINI Test Uses Genome-Wide Sequencing to Detect Cancer

New Method Facilitates Early Detection and Localization of Tumors

New Method Facilitates Early Detection and Localization of Tumors

New Method Reveals How Hepatitis C Virus Evades Immune System

New Method Reveals How Hepatitis C Virus Evades Immune System

New Study Sets the Stage to Help People Maintain Weight Loss After Dieting

New Study Sets the Stage to Help People Maintain Weight Loss After Dieting

New Genetic Marker Could Predict Lenvatinib Resistance in Hepatocellular Carcinoma

New Genetic Marker Could Predict Lenvatinib Resistance in Hepatocellular Carcinoma

Activated B Cells in Gastrointestinal Tract Contribute to the Development of Liver Cancer

Activated B Cells in Gastrointestinal Tract Contribute to the Development of Liver Cancer

Liver Cancers With Key Epigenetic Alteration Tend to Have a Poor Clinical Prognosis

Liver Cancers With Key Epigenetic Alteration Tend to Have a Poor Clinical Prognosis

Mini Organs Provide New Insights Into Fibrolamellar Carcinoma

Mini Organs Provide New Insights Into Fibrolamellar Carcinoma

CRISPR-Cas9 Driven Gene-Editing Tool Models Liver Cancer Tumor Subtypes

CRISPR-Cas9 Driven Gene-Editing Tool Models Liver Cancer Tumor Subtypes

Integrated-Gut-Liver-on-a-Chip can Improve Understanding of Non-Alcoholic Fatty Liver Disease

Integrated-Gut-Liver-on-a-Chip can Improve Understanding of Non-Alcoholic Fatty Liver Disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.